Stockreport

Evaxion appoints Dr Helen Tayton-Martin as new Chief Executive Officer

Evaxion Biotech A/S - American Depositary Share  (EVAX) 
PDF Dr Tayton-Martin brings broad experience of biotech company building, fund-raising, M&A, business development and operations with a strong track record of strategic part [Read more]